https://www.selleckchem.com/products/cc-99677.html
Postoperative pathology result showed that the patients got R0 resection. After radical surgery, the maintenance therapy including apatinib was given. The progression-free survival time was more than 10 months. Apatinib combined with SOX regimen as a conversion therapy for advanced gastric adenocarcinoma increases the possibility of successful surgical resection, which might prolong the survival time of patients. Deaths-related to medications errors are common in Pakistan but these are not accurately reported. Recently, the death of a
Like
Comment
Share
